Collplant Biotechnologies Ltd (CLGN) — Cash Flow Quality Index

Latest as of June 2023: -0.65x

Collplant Biotechnologies Ltd (CLGN) has a Cash Flow Quality Index of -0.65x as of June 2023. Operating cash flow of $-3.74 Million is below net income of $5.76 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore CLGN cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.65x
Operating CF / Net Income

Operating Cash Flow

$-3.74 Million
USD

Net Income

$5.76 Million
USD

Data as of

Jun 2023
Most recent filing

Collplant Biotechnologies Ltd Cash Flow Quality Index (2021–2021)

Historical Cash Flow Quality Index for Collplant Biotechnologies Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Collplant Biotechnologies Ltd.

Annual Cash Flow Quality Index for Collplant Biotechnologies Ltd (2021–2021)

Year-by-year earnings quality comparison for Collplant Biotechnologies Ltd.

Year Quality Index Operating CF (USD) Net Income YoY Change
2021 10.55x $2.50 Million $237.00K
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.